Sibylle Loibl

机构：Goethe University Frankfurt, German Breast Group · ORCID：0000-0001-6488-4958

发表论文 1509 篇 · 总被引 98396 次 · h-index 132

代表论文

• Preoperative immunotherapy in oncology (2026 · Deutsches Ärzteblatt international · 被引 1)
• Data from Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial (2026)
• Supplementary Data1 from Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial (2026)
• First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study (2026 · ESMO Open)
• Supplementary Table S4 from Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial (2025)
• Supplementary Figure S1 from Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial (2025)